Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Chase Manhattan

Article Abstract:

Chase Manhattan Bank is the biggest US bank and has assets of more than $300 billion. There are likely to be major cost savings from a merger with Chemical Bank, though there will also be one-off charges amounting to $1.7 billion. The bank controlled expenses well in 1st qtr 1996, while net earnings were up by almost a half. US banks face sluggish demand for loans as companies have developed cash reserves and consumers are less keen on taking on debt. Chase Manhattan is in a strong position in this difficult market.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
Company Profile, Chase Manhattan Bank N.A. (New York, New York)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Bull points for Lloyds

Article Abstract:

Lloyds TSB is a large UK bank which has been affected by weakness in the US bond market, but the group has a good growth record and has controlled costs well. UBS sees further group from the merger between Lloyds and TSB, while Merrill Lynch also sees a growth in business lending. Credit Lyonnais sees benefits from the merger. ABN AMRO notes that Cheltenham and Gloucester has low costs and is increasing its market share. SBC Warburg forecasts a pre-tax profit of 2,464 million pounds sterling for 1996.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1996
Lloyds TSB Group PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Banking industry, Commercial banks, Management
Similar abstracts:
  • Abstracts: Optimism at Boots. Rooting for Boots. Fill your Boots
  • Abstracts: Arts and antiques. Buying strategy. Aesthetic dividend is the only certainty
  • Abstracts: No easy answers in cheap Peps. Starting early. Guaranteed price to pay
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.